Share:
Peer-Reviewed Publication
Infect Control Hosp Epidemiol2022;43(5):651-653.May 1, 2022Journal Article

Geographic variability of antibiotic prescribing for acute respiratory tract infections within a direct-to-consumer telemedicine practice.

Rana F Hamdy1,2,3, Daniel Park2,3, Kristin Dean4, James Thompson4, Anusha Kambala2, Lily D Yan5, Ian Tong4,6, Cindy M Liu2,3
1Division of Infectious Diseases, Children's National Hospital, Washington, DC.
2George Washington University School of Medicine and Health Sciences, Washington, DC.
3Antibiotic Resistance Action Center, Department of Environmental and Occupational Health, George Washington Milken Institute of Public Health, Washington, DC.
4Doctor On Demand, San Francisco, California.
5Division of General Internal Medicine, Weill Cornell Medicine, New York, New York.
6Stanford University School of Medicine, Stanford, California.

Abstract

In this retrospective cohort study of patients presenting to a national direct-to-consumer medical practice, we found that provider geographic location is a stronger driver of antibiotic prescribing than patient location. Physicians in the Northeast and South are significantly more likely than physicians in the West to prescribe antibiotics for upper respiratory infection and bronchitis.

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.